• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

既往普通感冒冠状病毒暴露对老年集体照护机构中老年人严重急性呼吸综合征冠状病毒2疫苗接种免疫反应或感染风险的影响极小。

Minimal Impact of Prior Common Cold Coronavirus Exposure on Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination or Infection Risk in Older Adults in Congregate Care.

作者信息

Breznik Jessica A, Cowbrough Braeden, Bilaver Lucas, Dushoff Miriam, Stacey Hannah D, Ang Jann, Clare Rumi, Kennedy Allison, Costa Andrew P, Nazy Ishac, Loeb Mark, Verschoor Chris P, Bramson Jonathan, Miller Matthew S, Bowdish Dawn M E

机构信息

Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Ontario, Canada.

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

出版信息

Open Forum Infect Dis. 2025 May 1;12(5):ofaf178. doi: 10.1093/ofid/ofaf178. eCollection 2025 May.

DOI:10.1093/ofid/ofaf178
PMID:40313478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12044602/
Abstract

BACKGROUND

Common cold coronaviruses were a frequent cause of respiratory infections in older adults living in congregate care homes before the coronavirus disease 2019 pandemic, which may influence immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and infection. We investigated humoral and cellular immune responses to prior common cold coronaviruses and SARS-CoV-2, how they are affected by SARS-CoV-2 vaccination and infection, and their associations with Omicron BA.1 SARS-CoV-2 infections in residents of long-term care and retirement homes.

METHODS

In SARS-CoV-2 infection-naive residents with 3 monovalent messenger RNA SARS-CoV-2 vaccinations, we measured serum anti-receptor binding domain (RBD) immunoglobulin (Ig) G and IgA antibody titers against SARS-CoV-2 and common cold human coronavirus (HCoV) NL63, HCoV-OC43, and HCoV-229E; ancestral and Omicron BA.1 neutralizing antibodies; and CD4 and CD8 T-cell activation responses to membrane, nucleocapsid, and spike proteins. We examined the relationships of common cold coronavirus and SARS-CoV-2 humoral immune responses, whether antibody and T-cell responses changed after SARS-CoV-2 messenger RNA vaccination or infection, and their associations with Omicron BA.1 infection.

RESULTS

Anti-RBD IgG HCoV-OC43 titers were positively correlated with SARS-CoV-2 anti-RBD IgG and neutralizing antibody titers. Common cold coronavirus anti-RBD IgA titers, but not anti-RBD IgG titers, increased after SARS-CoV-2 vaccination or infection, and many residents had cross-reactive T cells. Common cold coronavirus humoral immunity was similar in residents without and those with subsequent Omicron BA.1 infection.

CONCLUSIONS

Despite frequent exposure, and associations of common cold coronavirus and vaccine-induced SARS-CoV-2 humoral immunity, preexisting common cold coronavirus immunity was not associated with Omicron BA.1 infection in residents of long-term care and retirement communities.

摘要

背景

在2019冠状病毒病大流行之前,普通感冒冠状病毒是居住在集体护理机构中的老年人呼吸道感染的常见原因,这可能会影响对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗接种和感染的免疫反应。我们调查了对先前普通感冒冠状病毒和SARS-CoV-2的体液免疫和细胞免疫反应,它们如何受到SARS-CoV-2疫苗接种和感染的影响,以及它们与长期护理和养老院居民中奥密克戎BA.1 SARS-CoV-2感染的关联。

方法

在未感染SARS-CoV-2且接种了3剂单价信使核糖核酸SARS-CoV-2疫苗的居民中,我们测量了血清中针对SARS-CoV-2以及普通感冒人类冠状病毒(HCoV)NL63、HCoV-OC43和HCoV-229E的抗受体结合域(RBD)免疫球蛋白(Ig)G和IgA抗体滴度;针对原始毒株和奥密克戎BA.1的中和抗体;以及对膜蛋白、核衣壳蛋白和刺突蛋白的CD4和CD8 T细胞活化反应。我们研究了普通感冒冠状病毒和SARS-CoV-2体液免疫反应之间的关系,SARS-CoV-2信使核糖核酸疫苗接种或感染后抗体和T细胞反应是否发生变化,以及它们与奥密克戎BA.1感染的关联。

结果

抗RBD IgG HCoV-OC43滴度与SARS-CoV-2抗RBD IgG和中和抗体滴度呈正相关。SARS-CoV-2疫苗接种或感染后,普通感冒冠状病毒抗RBD IgA滴度升高,但抗RBD IgG滴度未升高,且许多居民有交叉反应性T细胞。在未感染奥密克戎BA.1和感染奥密克戎BA.1的居民中,普通感冒冠状病毒体液免疫相似。

结论

尽管长期暴露,且普通感冒冠状病毒与疫苗诱导的SARS-CoV-2体液免疫有关,但长期护理和退休社区居民中,既往普通感冒冠状病毒免疫与奥密克戎BA.1感染无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e9/12044602/1987f141d5b3/ofaf178f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e9/12044602/0117ed5db933/ofaf178f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e9/12044602/d6d10dfb8059/ofaf178f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e9/12044602/1987f141d5b3/ofaf178f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e9/12044602/0117ed5db933/ofaf178f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e9/12044602/d6d10dfb8059/ofaf178f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58e9/12044602/1987f141d5b3/ofaf178f3.jpg

相似文献

1
Minimal Impact of Prior Common Cold Coronavirus Exposure on Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination or Infection Risk in Older Adults in Congregate Care.既往普通感冒冠状病毒暴露对老年集体照护机构中老年人严重急性呼吸综合征冠状病毒2疫苗接种免疫反应或感染风险的影响极小。
Open Forum Infect Dis. 2025 May 1;12(5):ofaf178. doi: 10.1093/ofid/ofaf178. eCollection 2025 May.
2
Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: An observational cohort study.在加拿大安大略省长期护理和退休之家居民中接种二价 SARS-CoV-2 mRNA-1273.214 疫苗后的早期体液和细胞反应:一项观察性队列研究。
J Med Virol. 2023 Oct;95(10):e29170. doi: 10.1002/jmv.29170.
3
Vaccination against SARS-CoV-2 provides low-level cross-protection against common cold coronaviruses in mouse and non-human primate animal models.在小鼠和非人类灵长类动物模型中,接种针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的疫苗可提供针对普通感冒冠状病毒的低水平交叉保护。
J Virol. 2025 Feb 25;99(2):e0139024. doi: 10.1128/jvi.01390-24. Epub 2025 Jan 16.
4
Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting.由于疫苗接种和奥密克戎 SARS-CoV-2 感染导致的针对异源抗原暴露的体液免疫反应趋势:对增强作用的影响。
Indian J Med Res. 2023 Jun;157(6):509-518. doi: 10.4103/ijmr.ijmr_2521_22.
5
Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing antibody and T-cell responses after Omicron bivalent booster vaccination in previously infected and infection-naive individuals.先前感染和未感染个体接种奥密克戎二价加强针后针对原始 SARS-CoV-2 和奥密克戎 BA.5 的中和抗体和 T 细胞应答。
J Med Virol. 2023 Aug;95(8):e28989. doi: 10.1002/jmv.28989.
6
Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.检测血清交叉反应抗体和对 SARS-CoV-2 的记忆反应在大流行前和 COVID-19 后恢复期样本中。
J Infect Dis. 2021 Oct 28;224(8):1305-1315. doi: 10.1093/infdis/jiab333.
7
Neutralizing Activity and T-Cell Responses Against Wild Type SARS-CoV-2 Virus and Omicron BA.5 Variant After Ancestral SARS-CoV-2 Vaccine Booster Dose in PLWH Receiving ART Based on CD4 T-Cell Count.在接受基于CD4 T细胞计数的抗逆转录病毒治疗的艾滋病毒感染者中,原始SARS-CoV-2疫苗加强剂量后针对野生型SARS-CoV-2病毒和奥密克戎BA.5变体的中和活性及T细胞反应
J Korean Med Sci. 2025 Mar 10;40(9):e28. doi: 10.3346/jkms.2025.40.e28.
8
Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?针对季节性人类冠状病毒的抗体水平较高是否与接种 SARS-CoV-2 疫苗后更强大的体液免疫反应有关?
Front Immunol. 2022 Sep 8;13:954093. doi: 10.3389/fimmu.2022.954093. eCollection 2022.
9
Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.既往抗 HCoV-OC43 免疫影响 SARS-CoV-2 疫苗接种后体液免疫的持久性和交叉反应性。
Front Cell Infect Microbiol. 2022 Sep 2;12:978440. doi: 10.3389/fcimb.2022.978440. eCollection 2022.
10
Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.地方性冠状病毒的抗 RBD IgG 抗体不能预防暴露于未感染者中 SARS-CoV-2 感染的发生。
Front Immunol. 2024 May 23;15:1396603. doi: 10.3389/fimmu.2024.1396603. eCollection 2024.

本文引用的文献

1
Heterotypic immunity from prior SARS-CoV-2 infection but not COVID-19 vaccination associates with lower endemic coronavirus incidence.先前 SARS-CoV-2 感染产生的异源免疫,但不是 COVID-19 疫苗接种,与较低的地方性冠状病毒发病率相关。
Sci Transl Med. 2024 Jun 12;16(751):eado7588. doi: 10.1126/scitranslmed.ado7588.
2
Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.地方性冠状病毒的抗 RBD IgG 抗体不能预防暴露于未感染者中 SARS-CoV-2 感染的发生。
Front Immunol. 2024 May 23;15:1396603. doi: 10.3389/fimmu.2024.1396603. eCollection 2024.
3
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents.
血清人冠状病毒刺突蛋白特异性抗体不能预防儿童和青少年后续感染新型冠状病毒。
iScience. 2023 Nov 21;26(12):108500. doi: 10.1016/j.isci.2023.108500. eCollection 2023 Dec 15.
4
The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023.SARS-CoV-2 血清流行率在加拿大的演变:2020-2023 年的时间序列研究。
CMAJ. 2023 Aug 14;195(31):E1030-E1037. doi: 10.1503/cmaj.230249.
5
Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis.预测疫苗对 COVID-19 重症的长期有效性和对变异株的有效性:一项荟萃分析。
Nat Commun. 2023 Mar 24;14(1):1633. doi: 10.1038/s41467-023-37176-7.
6
Nursing home crowding and its association with outbreak-associated respiratory infection in Ontario, Canada before the COVID-19 pandemic (2014-19): a retrospective cohort study.加拿大安大略省 COVID-19 大流行前(2014-19 年)养老院拥挤及其与暴发相关呼吸道感染的关系:一项回顾性队列研究。
Lancet Healthy Longev. 2023 Mar;4(3):e107-e114. doi: 10.1016/S2666-7568(23)00018-1.
7
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses.预先存在的交叉反应性免疫对 SARS-CoV-2 感染和疫苗反应的影响。
Nat Rev Immunol. 2023 May;23(5):304-316. doi: 10.1038/s41577-022-00809-x. Epub 2022 Dec 20.
8
Infections, Hospitalizations, and Deaths Among US Nursing Home Residents With vs Without a SARS-CoV-2 Vaccine Booster.美国有与无 SARS-CoV-2 疫苗加强针的养老院居民中的感染、住院和死亡情况。
JAMA Netw Open. 2022 Dec 1;5(12):e2245417. doi: 10.1001/jamanetworkopen.2022.45417.
9
Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination.老年人巨细胞病毒血清阳性改变 T 细胞库,但不预防对 SARS-CoV-2 疫苗的抗体或细胞反应。
J Immunol. 2022 Nov 15;209(10):1892-1905. doi: 10.4049/jimmunol.2200369.
10
COVID-19 and children.新型冠状病毒肺炎与儿童。
Science. 2022 Sep 9;377(6611):1144-1149. doi: 10.1126/science.ade1675. Epub 2022 Sep 8.